Literature DB >> 32931108

Effectiveness of cognitive remediation in the ultra-high risk state for psychosis.

Louise B Glenthøj1,2, Lise S Mariegaard1, Birgitte Fagerlund2,3,4, Jens R M Jepsen2,3,5, Tina D Kristensen1,2, Christina Wenneberg1,2,6, Kristine Krakauer1,2,6, Alice Medalia7, David L Roberts8, Carsten Hjorthøj1,9, Merete Nordentoft1,2.   

Abstract

Entities:  

Year:  2020        PMID： 32931108      PMCID： PMC7491627          DOI： 10.1002/wps.20760

Source DB:  PubMed          Journal:  World Psychiatry        ISSN： 1723-8617            Impact factor:   49.548


× No keyword cloud information.
  7 in total

1.  Beyond the "at risk mental state" concept: transitioning to transdiagnostic psychiatry.

Authors:  Patrick D McGorry; Jessica A Hartmann; Rachael Spooner; Barnaby Nelson
Journal:  World Psychiatry       Date:  2018-06       Impact factor: 49.548

2.  Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trial.

Authors:  Luke K Bolt; G Paul Amminger; John Farhall; Patrick D McGorry; Barnaby Nelson; Connie Markulev; Hok Pan Yuen; Miriam R Schäfer; Nilufar Mossaheb; Monika Schlögelhofer; Stefan Smesny; Ian B Hickie; Gregor Emanuel Berger; Eric Y H Chen; Lieuwe de Haan; Dorien H Nieman; Merete Nordentoft; Anita Riecher-Rössler; Swapna Verma; Andrew Thompson; Alison Ruth Yung; Kelly A Allott
Journal:  Schizophr Res       Date:  2018-12-14       Impact factor: 4.939

3.  Interventions and social functioning in youth at risk of psychosis: A systematic review and meta-analysis.

Authors:  Daniel J Devoe; Megan S Farris; Parker Townes; Jean Addington
Journal:  Early Interv Psychiatry       Date:  2018-06-25       Impact factor: 2.732

Review 4.  Brain maturational processes and delayed onset in schizophrenia.

Authors:  M S Keshavan; G E Hogarty
Journal:  Dev Psychopathol       Date:  1999

5.  Cognitive remediation for severe mental illness: state of the field and future directions.

Authors:  Christopher R Bowie
Journal:  World Psychiatry       Date:  2019-10       Impact factor: 49.548

6.  A meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes.

Authors:  Til Wykes; Vyv Huddy; Caroline Cellard; Susan R McGurk; Pál Czobor
Journal:  Am J Psychiatry       Date:  2011-03-15       Impact factor: 18.112

7.  The FOCUS trial: cognitive remediation plus standard treatment versus standard treatment for patients at ultra-high risk for psychosis: study protocol for a randomised controlled trial.

Authors:  Louise B Glenthøj; Birgitte Fagerlund; Lasse Randers; Carsten R Hjorthøj; Christina Wenneberg; Kristine Krakauer; Astrid Vosgerau; Christian Gluud; Alice Medalia; David L Roberts; Merete Nordentoft
Journal:  Trials       Date:  2015-01-27       Impact factor: 2.279
  7 in total
  7 in total

Review 1.  European Psychiatric Association guidance on treatment of cognitive impairment in schizophrenia.

Authors:  Antonio Vita; Wolfgang Gaebel; Armida Mucci; Gabriele Sachs; Stefano Barlati; Giulia Maria Giordano; Gabriele Nibbio; Merete Nordentoft; Til Wykes; Silvana Galderisi
Journal:  Eur Psychiatry       Date:  2022-09-05       Impact factor: 7.156

2.  Self-perceived cognitive impairments in psychosis ultra-high risk individuals: associations with objective cognitive deficits and functioning.

Authors:  Louise Birkedal Glenthøj; Lise Mariegaard; Tina Dam Kristensen; Christina Wenneberg; Alice Medalia; Merete Nordentoft
Journal:  NPJ Schizophr       Date:  2020-11-13

3.  We Should Improve Personalization of Management in Patients with a Diagnosis of Schizophrenia.

Authors:  Alfonso Tortorella
Journal:  J Clin Med       Date:  2021-12-30       Impact factor: 4.241

4.  Social Cognition Individualized Activities Lab for Social Cognition Training and Narrative Enhancement in Patients With Schizophrenia: A Randomized Controlled Study to Assess Efficacy and Generalization to Real-Life Functioning (Prot. n°: NCT05130853).

Authors:  Davide Palumbo; Edoardo Caporusso; Giuseppe Piegari; Claudio Mencacci; Sara Torriero; Luigi Giuliani; Michele Fabrazzo; Dario Pinto; Silvana Galderisi
Journal:  Front Psychiatry       Date:  2022-04-04       Impact factor: 4.157

5.  Schizophrenia: A Narrative Review of Etiopathogenetic, Diagnostic and Treatment Aspects.

Authors:  Laura Orsolini; Simone Pompili; Umberto Volpe
Journal:  J Clin Med       Date:  2022-08-27       Impact factor: 4.964

Review 6.  Factors influencing the outcome of integrated therapy approach in schizophrenia: A narrative review of the literature.

Authors:  Giulia M Giordano; Francesco Brando; Pasquale Pezzella; Maria De Angelis; Armida Mucci; Silvana Galderisi
Journal:  Front Psychiatry       Date:  2022-08-30       Impact factor: 5.435

7.  Investigating the Relationships of P3b with Negative Symptoms and Neurocognition in Subjects with Chronic Schizophrenia.

Authors:  Giulia M Giordano; Andrea Perrottelli; Armida Mucci; Giorgio Di Lorenzo; Mario Altamura; Antonello Bellomo; Roberto Brugnoli; Giulio Corrivetti; Paolo Girardi; Palmiero Monteleone; Cinzia Niolu; Silvana Galderisi; Mario Maj
Journal:  Brain Sci       Date:  2021-12-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.